Treatment Resistant Depression Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine
The global treatment resistant depression market is expected to grow at a CAGR of around 6.3% during 2025-2034. This report on global treatment resistant depression market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global treatment resistant depression market by segmenting the market based on route of administration, end user, drug class, distribution channel and region. Also, detailed profiles of companies operating in the treatment resistant depression market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increased Research and Clinical Activities
• Increased Prevalence of Product Launches
Market Challenges
• High Costs
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Route of Administration
• Oral
• Parenteral
• Other Route of Administration
Market by End-User
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
Market by Drug Class
• Selective Serotonin Reuptake Inhibitors (SSRIS)
• Monoamine Oxidase Inhibitors
• Tricyclic Antidepressant
• Psychedelics
• Other Drug Classes
Market by Distribution Channel
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Treatment Resistant Depression Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Treatment Resistant Depression Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Size
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Treatment Resistant Depression Market by Route of Administration
- 5.1. Introduction
- 5.2. Oral
- 5.3. Parenteral
- 5.4. Other Route of Administration
- 6. Global Treatment Resistant Depression Market by End-User
- 6.1. Introduction
- 6.2. Hospitals
- 6.3. Homecare
- 6.4. Specialty Clinics
- 6.5. Other End-Users
- 7. Global Treatment Resistant Depression Market by Drug Class
- 7.1. Introduction
- 7.2. Selective Serotonin Reuptake Inhibitors (SSRIS)
- 7.3. Monoamine Oxidase Inhibitors
- 7.4. Tricyclic Antidepressant
- 7.5. Psychedelics
- 7.6. Other Drug Classes
- 8. Global Treatment Resistant Depression Market by Distribution Channel
- 8.1. Introduction
- 8.2. Hospital Pharmacy
- 8.3. Online Pharmacy
- 8.4. Retail Pharmacy
- 9. Global Treatment Resistant Depression Market by Region
- 9.1. Introduction
- 9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Russia
- 9.2.7. Netherlands
- 9.2.8. Rest of the Europe
- 9.3. North America
- 9.3.1. United States
- 9.3.2. Canada
- 9.4. Asia Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. South Korea
- 9.4.5. Australia
- 9.4.6. Indonesia
- 9.4.7. Rest of the Asia Pacific
- 9.5. Latin America
- 9.5.1. Mexico
- 9.5.2. Brazil
- 9.5.3. Argentina
- 9.5.4. Rest of Latin America
- 9.6. Middle East & Africa
- 9.6.1. Saudi Arabia
- 9.6.2. Turkey
- 9.6.3. Iran
- 9.6.4. United Arab Emirates
- 9.6.5. Rest of Middle East & Africa
- 10. SWOT Analysis
- 11. Porter’s Five Forces
- 12. Market Value Chain Analysis
- 13. Competitive Landscape
- 13.1. Competitive Scenario
- 13.2. Company Profiles
- 13.2.1. Brusa ELectronik.
- 13.2.2. Continental AG
- 13.2.3. Dana Incorporated
- 13.2.4. Denso Corporation
- 13.2.5. Hitachi Automotive
- 13.2.6. Magna International Inc.
- 13.2.7. Magneti Marelli Ck Holdings
- 13.2.8. Marelli Holdings Co., Ltd.
- 13.2.9. Nidec Corporation
- 13.2.10. Panasonic Holdings Corporation
- 13.2.11. Robert Bosch GmbH
- 13.2.12. Schaeffler AG
- 13.2.13. Toyota Industries Corporation
- 13.2.14. Valeo Group
- 13.2.15. ZF Friedrichshafen AG
- List of Figures
- Figure 1: Global Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 2: Global Treatment Resistant Depression Market by Route of Administration, 2024
- Figure 3: Global Treatment Resistant Depression Market by End-User, 2024
- Figure 4: Global Treatment Resistant Depression Market by Drug Class, 2024
- Figure 5: Global Treatment Resistant Depression Market by Distribution Channel, 2024
- Figure 6: Global Treatment Resistant Depression Market by Region, 2024
- Figure 7: Global Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 8: Global Treatment Resistant Depression Market by Route of Administration (in %), 2024 & 2034
- Figure 9: Global Oral Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 10: Global Oral Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 11: Global Parenteral Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 12: Global Parenteral Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 13: Global Other Route of Administration Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 14: Global Other Route of Administration Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 15: Global Treatment Resistant Depression Market by End-User (in %), 2024 & 2034
- Figure 16: Global Hospitals Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 17: Global Hospitals Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 18: Global Homecare Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 19: Global Homecare Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 20: Global Specialty Clinics Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 21: Global Specialty Clinics Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 22: Global Other End-Users Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 23: Global Other End-Users Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 24: Global Treatment Resistant Depression Market by Drug Class (in %), 2024 & 2034
- Figure 25: Global Selective Serotonin Reuptake Inhibitors (SSRIS) Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 26: Global Selective Serotonin Reuptake Inhibitors (SSRIS) Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 27: Global Monoamine Oxidase Inhibitors Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 28: Global Monoamine Oxidase Inhibitors Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 29: Global Tricyclic Antidepressant Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 30: Global Tricyclic Antidepressant Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 31: Global Psychedelics Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 32: Global Psychedelics Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 33: Global Other Drug Classes Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 34: Global Other Drug Classes Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 35: Global Treatment Resistant Depression Market by Distribution Channel (in %), 2024 & 2034
- Figure 36: Global Hospital Pharmacy Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 37: Global Hospital Pharmacy Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 38: Global Online Pharmacy Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 39: Global Online Pharmacy Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 40: Global Retail Pharmacy Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 41: Global Retail Pharmacy Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 42: Global Treatment Resistant Depression Market by Region (in %), 2024 & 2034
- Figure 43: Europe Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 44: Europe Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 45: Europe Treatment Resistant Depression Market by Country (in %), 2024 & 2034
- Figure 46: Germany Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 47: United Kingdom Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 48: France Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 49: Italy Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 50: Spain Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 51: Russia Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 52: Netherlands Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 53: North America Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 54: North America Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 55: North America Treatment Resistant Depression Market by Country (in %), 2024 & 2034
- Figure 56: United States Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 57: Canada Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 58: Asia Pacific Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 59: Asia Pacific Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 60: Asia Pacific Treatment Resistant Depression Market by Country (in %), 2024 & 2034
- Figure 61: China Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 62: Japan Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 63: India Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 64: South Korea Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 65: Australia Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 66: Indonesia Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 67: Latin America Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 68: Latin America Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 69: Latin America Treatment Resistant Depression Market by Country (in %), 2024 & 2034
- Figure 70: Mexico Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 71: Brazil Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 72: Argentina Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 73: Middle East & Africa Treatment Resistant Depression Market (in US$ Million), 2020-2024
- Figure 74: Middle East & Africa Treatment Resistant Depression Market (in US$ Million), 2025-2034
- Figure 75: Middle East & Africa Treatment Resistant Depression Market by Country (in %), 2024 & 2034
- Figure 76: Saudi Arabia Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 77: Turkey Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 78: Iran Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 79: UAE Treatment Resistant Depression Market (in US$ Million), 2020-2034
- Figure 80: Market Value Chain
- List of Tables
- Table 1: Global Treatment Resistant Depression Market Portraiture
- Table 2: Global Treatment Resistant Depression Market by Route of Administration (in US$ Million), 2024 & 2034
- Table 3: Global Treatment Resistant Depression Market by End-User (in US$ Million), 2024 & 2034
- Table 4: Global Treatment Resistant Depression Market by Drug Class (in US$ Million), 2024 & 2034
- Table 5: Global Treatment Resistant Depression Market by Distribution Channel (in US$ Million), 2024 & 2034
- Table 6: Global Treatment Resistant Depression Market by Region (in US$ Million), 2024 & 2034
- Table 7: Europe Treatment Resistant Depression Market by Country (in US$ Million), 2024 & 2034
- Table 8: North America Treatment Resistant Depression Market by Country (in US$ Million), 2024 & 2034
- Table 9: Asia Pacific Treatment Resistant Depression Market by Country (in US$ Million), 2024 & 2034
- Table 10: Latin America Treatment Resistant Depression Market by Country (in US$ Million), 2024 & 2034
- Table 11: Middle East & Africa Treatment Resistant Depression Market by Country (in US$ Million),
- 2024 & 2034
- Table 12: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook